BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18521604)

  • 1. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B.
    Zhang M; Zhang H; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):635-42. PubMed ID: 18521604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].
    Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling.
    Zhang M; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
    Pancreas; 2010 Aug; 39(6):923-9. PubMed ID: 20182390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
    Liu T; Peng H; Zhang M; Deng Y; Wu Z
    Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration.
    Chan KT; Meng FY; Li Q; Ho CY; Lam TS; To Y; Lee WH; Li M; Chu KH; Toh M
    Cancer Lett; 2010 Aug; 294(1):118-24. PubMed ID: 20153103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma.
    Liu T; Zhang M; Zhang H; Sun C; Deng Y
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1225-32. PubMed ID: 18309509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
    Liu T; Zhang M; Zhang H; Sun C; Yang X; Deng Y; Ji W
    Eur J Pharmacol; 2008 Jun; 587(1-3):78-84. PubMed ID: 18442812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
    Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
    Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
    Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M; Li C; Lin J; Javle M
    Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro.
    Zhang JF; Liu JJ; Lu MQ; Cai CJ; Yang Y; Li H; Xu C; Chen GH
    Transpl Immunol; 2007 Apr; 17(3):162-8. PubMed ID: 17331842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
    Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
    J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
    Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
    Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells.
    Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D
    Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
    Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.